Microfluidic Microdroplet Technology for Custom Materials Discovery & Manufacturing

Unique combination of materials (atoms, molecules, inks).
Microdroplet (microliter to picoliter volume) flow reactions generate a library of materials.
Iterate to identify the best candidates.
Seamlessly scale up using the same setup.
Continuous and distributed sustainable manufacturing.
Automation and machine learning enabled.

Toolbox to Customize
Composition, structure & Function

Starting Material Options

Materials with sp2 carbon sources (e.g., graphite, graphene, carbon nanotube, fullerenes, acrylates), or form condensates (e.g., hydrogels, sol-gels) such as silanes, glycols, agarose, dextran, imines, amino acids, and their blends.

Graphite

Acrylates

Agarose

Amino Acids

Silica

Crosslinker Options

Hydrophobic (e.g., alkyl) or hydrophilic (e.g., polyethylene glycol (PEG)) with variable lengths and functional (e.g., epoxides, proteins) groups.

Alkyl

PEG

Epoxides

Proteins

Additives Options

Atoms (e.g., Iron, Copper) and molecules (e.g., porogens) to manipulate the physical and chemical properties.

Atoms

Molecules

Applications

Chemical & Biochemical Separation (current focus).

Other high-tech industries.
- Biomedical (e.g., biologic drug microcapsules).
- Energy (e.g., active materials)
- Agriculture (e.g., microcarriers for cellular agriculture).

Chemical & Biochemical Separation

Carbon Microbead Platform

underpins the current suite of:

NanoPak-C All-Carbon Materials for Reverse Phase & Hydrophobic Interaction Liquid Chromatography.

NanoPak-M Functionalized Carbon Materials for Multimodal Liquid Chromatography.

NanoPak-E Electrically Conducting Carbon Materials for Electrochemically Modulated Liquid Chromatography.

Launching Soon

Harnessing the technology to develop product offerings to process chromatography.

Bulk media (agarose, polymeric) tailored to specific purification (affinity, ion exchange) challenges for customers working on niche biological products such as non-antibody proteins, nucleic acids, viral vectors, vaccines, and therapeutic cells.